Search research articles
Contact Us
Filters
Showing results (551-560 of 627) with videos related to
Page
of 63
Sort By:
Nature
|
August 31, 2017
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Louis J Cohen, Daria Esterhazy, Seong-Hwan Kim, et al.
Molecular Cancer Therapeutics
|
December 14, 2002
A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo
Deborah DeFeo-Jones, Stephen F Brady, Dong-Mei Feng, et al.
Journal of Medical Genetics
|
October 9, 2023
Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome
Anthony M Vandersteen, Ruwan A Weerakkody, David A Parry, et al.
Current Oncology (Toronto, Ont.)
|
October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective
A M Oza, V Castonguay, D Tsoref, et al.
The Lancet. Oncology
|
April 26, 2017
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Robert L Coleman, Mark F Brady, Thomas J Herzog, et al.
JAMA Oncology
|
January 1, 2016
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M Norquist, Maria I Harrell, Mark F Brady, et al.
Gynecologic Oncology
|
February 1, 2011
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations
Robin A Lacour, Shannon N Westin, Larissa A Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M Norquist, Mark F Brady, Maria I Harrell, et al.
The Journal of Urology
|
January 1, 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area
M S Soloway, S Beckley, M F Brady, et al.
British Journal of Cancer
|
February 20, 2022
Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service
Eamonn R Maher, Julian Adlard, Julian Barwell, et al.
Page
of 63
Search research articles
Search
Showing results (551-560 of 627) with videos related to
Sort By:
Page
of 63
Nature
|
August 31, 2017
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Louis J Cohen, Daria Esterhazy, Seong-Hwan Kim, et al.
Molecular Cancer Therapeutics
|
December 14, 2002
A prostate-specific antigen (PSA)-activated vinblastine prodrug selectively kills PSA-secreting cells in vivo
Deborah DeFeo-Jones, Stephen F Brady, Dong-Mei Feng, et al.
Journal of Medical Genetics
|
October 9, 2023
Genetic complexity of diagnostically unresolved Ehlers-Danlos syndrome
Anthony M Vandersteen, Ruwan A Weerakkody, David A Parry, et al.
Current Oncology (Toronto, Ont.)
|
October 5, 2011
Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective
A M Oza, V Castonguay, D Tsoref, et al.
The Lancet. Oncology
|
April 26, 2017
Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
Robert L Coleman, Mark F Brady, Thomas J Herzog, et al.
JAMA Oncology
|
January 1, 2016
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M Norquist, Maria I Harrell, Mark F Brady, et al.
Gynecologic Oncology
|
February 1, 2011
Improved survival in non-Ashkenazi Jewish ovarian cancer patients with BRCA1 and BRCA2 gene mutations
Robin A Lacour, Shannon N Westin, Larissa A Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 2, 2017
Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study
Barbara M Norquist, Mark F Brady, Maria I Harrell, et al.
The Journal of Urology
|
January 1, 1983
A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area
M S Soloway, S Beckley, M F Brady, et al.
British Journal of Cancer
|
February 20, 2022
Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service
Eamonn R Maher, Julian Adlard, Julian Barwell, et al.
Page
of 63